Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $500M Series E (Mar 2026) at $3.75B valuation backed by NVIDIA and AMD. TeraPHY UCIe chiplet entering volume production. 8 Tbps per package — first UCIe-compliant optical interconnect.
Ayar Labs develops optical interconnect chiplets that replace copper wires inside AI servers and data centers with silicon photonics — eliminating the bandwidth wall that throttles GPU cluster performance. The company raised $500 million in Series E financing in March 2026 at a $3.75 billion valuation, with both NVIDIA and AMD as co-investors — the two dominant AI chip companies betting on Ayar's technology appearing inside next-generation accelerators.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.